levonorgestrel has been researched along with Bone Loss, Perimenopausal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorai, I; Honjo, H; Itabashi, A; Mizunuma, H; Ohta, H; Shiraki, M; Taketani, Y | 1 |
| Shulman, LP | 1 |
| Christiansen, C; Ravn, P; Warming, L | 1 |
| Byrjalsen, I; Christiansen, C; Haarbo, J | 1 |
| Christiansen, C; Marslew, U; Overgaard, K; Riis, BJ | 1 |
| Everett, M; Hay, AW; Purdie, DW | 1 |
1 review(s) available for levonorgestrel and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Evidence-Based Medicine; Female; Hot Flashes; Humans; Levonorgestrel; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk Factors; United States; Women's Health | 2004 |
5 trial(s) available for levonorgestrel and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Dose effects of oral estradiol on bone mineral density in Japanese women with osteoporosis.
Topics: Aged; Biomarkers; Bone Density; Bone Remodeling; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Female; Humans; Japan; Levonorgestrel; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy; Placebos | 2010 |
Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Topics: Administration, Cutaneous; Aged; Alkaline Phosphatase; Biomarkers; Bone Density; Collagen; Contraceptives, Oral, Synthetic; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Prospective Studies; Treatment Outcome | 2005 |
Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestogen therapy.
Topics: Desogestrel; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Isocitrate Dehydrogenase; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Pregnancy Proteins; Smoking | 1993 |
Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Topics: Bone and Bones; Bone Density; Calcium; Climacteric; Cyproterone; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Uterine Hemorrhage | 1992 |
Short term effects of SHD 386L and levonorgestrel on bone and mineral metabolism in the postmenopause: a double-blind randomised placebo-controlled trial.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Creatinine; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyproline; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Minerals; Osteocalcin; Osteoporosis, Postmenopausal; Time Factors | 1992 |